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OBJECTIVES: The aim of this study was to search for evidence of stem or progenitor cells in the adult human
cochlea by testing for sphere formation capacity and the presence of the stem cell marker ABCG2.
METHODS: Cochleas removed from patients undergoing vestibular schwannoma resection (n=2) and from
brain-dead organ donors (n=4) were dissociated for either flow cytometry analysis for the stem cell marker
ABCG2 or a sphere formation assay that is widely used to test the sphere-forming capacity of cells from mouse
inner ear tissue.
RESULTS: Spheres were identified after 2-5 days in vitro, and the stem cell marker ABCG2 was detected using
flow cytometric analysis after cochlear dissociation.
CONCLUSIONS: Evidence suggests that there may be progenitor cells in the adult human cochlea, although
further studies are required.
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’ INTRODUCTION
Hearing loss is one of the most common sensorial deficiencies
in humans. Although there exist several options for treat-
ing hearing loss, none of these approaches can completely
reestablish auditory physiology. Prosthetic devices require
maintenance and have inherent daily limitations due to their
electrical nature; many such devices are simply not designed
to be used while sleeping. One possible strategy to reestablish
auditory physiology is the replacement of lost sensorial cells.
In theory, the discovery of adult stem cells in the cochlea
would bring this possibility closer to clinical practice.
No prior studies have attempted to find evidence of stem
cells in the adult human cochlea. The availability of human
cochlear tissue is limited, and most authors have chosen
to use cochleas from patients who are undergoing surgical
procedures that suggest permanent hearing loss (1-4). The
only references to human cochlear stem cells involve fetal
specimens (5-6).
Sphere formation assays have been used to demonstrate
the proliferative capacity of neonatal mammalian cochleas in
different species (7-9). Spheres have also been identified in
adult mice, although such spheres were not numerous, could
not differentiate in vitro and exhibited few developmental
markers (10). In neonatal mice, there also exists evidence
of a side population of cochlear cells that express the stem
cell marker ABCG2 and are capable of in vitro proliferation,
self-renovation and differentiation (11-14).
The aim of this study was to identify evidence of progen-
itor or stem cells in the adult human cochlea. To test our
hypothesis, we used cochleas removed from patients under-
going vestibular schwannoma (VS) resection and brain-dead
organ donors; this article is the first report involving the use
of cochlear tissue from organ donors.
’ MATERIALS AND METHODS
Patients
Cochlear samples were obtained from patients undergoing
excision of a VS via a translabyrinthine approach (n=2) and
brain-dead organ donors (n=4) at University of Sao Paulo
Clinics Hospital. All patients or their legal representatives
provided informed consent prior to tissue collection in
accordance with requirements of local and national ethics
committees.
Surgery in the VS group
A translabyrinthine approach was utilized by the same
surgeon for both patients, and cochlear access was achieved
as described by Browne and Fisch (15). After cochlear
exposure, a wide cochleotomy was performed to allow for
tissue removal. The membranous portion of the cochlea was
collected into culture medium for immediate transport to
the laboratory.DOI: 10.6061/clinics/2017(11)11
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Tissue collection in the organ donor group
To reach the cochlear promontory, three different approaches
were tested. On one side, we used an endaural approach;
on the remaining sides, retroauricular access was established
to perform a mastoidectomy. On four sides, a posterior
tympanotomy was conducted to gain access to the cochlear
promontory. On one side, the posterior wall of the external
auditory canal was drilled away to improve cochlear
visualization. In all cases, after cochlear exposure, a wide
cochleotomy was performed to allow for tissue removal.
The membranous portion of the cochlea was collected into
culture medium for immediate transport to the laboratory.
Sphere formation assay
To test the ability of removed cochlear tissue to form
spheres, we used the protocol described by Oshima et al. (16).
Briefly, tissue was inspected with an inverted microscope,
dissociated with trypsin, mechanically passed through a
70 mm filter and cultured under non-adherent conditions
on defined media (DMEM-F12 with 2 B-27, 1 N2, 2 mM
glutamine, 2 mL/mL ITS, 6 g/L glucose, 0.2 mL/mL ampicillin,
20 ng/mL EGF, 10 ng/mL bFGF and 50 ng/mL IGF) for up to
five days.
Flow cytometry
To verify the presence of the stem cell marker ABCG2,
removed cochlear tissue was transferred to the laboratory in
Eagle’s minimum essential medium (EMEM; Vitrocell Embrio-
life, Campinas, SP, Brazil). Due to limited equipment avail-
ability, samples remained at 4oC for up to 36 hours; they were
then dissociated with trypsin and mechanically dissociated (16)
for antibody incubation in accordance with the manufac-
turer ’s instructions.
We used an anti-ABCG2 antibody (Biolegend, 332020, San
Diego, CA, USA) and its isotype (Biolegend, 401209), and
flow cytometric analysis was performed on an Attunes NxT
Acoustic Focusing Cytometer (Thermo Fisher Scientific, Inc.,
Waltham, MA, USA).
’ RESULTS
Patients and tissue collection
The patients in the VS group (both female) were 61 and
63 years of age, and those in the organ donor group (2 males
and 2 females) were 17-55 years of age. Both patients had
moderate unilateral sensorineural hearing loss. In the organ
donor group, six of the eight available sides were used.
We have no auditory testing data from this group.
There was great variability in the quantities of tissue
collected from patients and organ donors. In all cases, a por-
tion of the organ of Corti and stria vascularis could be
identified. In the organ donor group, the greatest quantity of
tissue was collected when we used a retroauricular approach
followed by mastoidectomy with drilling of the posterior
wall of the external auditory canal. In the VS group, vari-
ability in tissue quantities was mainly attributable to anatomical
variations. Figure 1 depicts a section of the membranous
portion of the cochlea shortly after its removal from a
patient undergoing VS resection.
Identification of spheres
Three independent sphere formation assays were performed.
Two of these assays used samples from the VS group (involv-
ing one cochlea each), and the remaining assay utilized a
sample from the organ donor group (with two cochleas assessed
in the same experiment). The evaluated cochleas were from
61- and 63-year-old female patients who were undergoing
surgery and a 17-year-old male organ donor.
Spheres were identified in two of the three experiments
(Figure 2).
Identification of ABCG2
Four cochleas from three organ donors were used for
flow cytometric identification of ABCG2. The donors
included one 38-year-old male and 33- and 55-year-old
females. There was a clear population of ABCG2-positive
Figure 1 -Membranous portion of the cochlea that was removed
from a patient undergoing VS resection.
Figure 2 - Sphere identification for samples from 2A, a 61-year-old female undergoing VS resection at 5 DIV; 2B, a 17-year-old male
organ donor at 3 DIV; and 2C, a 17-year-old male organ donor at 5 DIV.
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cells in the dissociated cochlea from the 33-year-old female
(Figure 3).
Comparative table of results
’ DISCUSSION
This article is the first report describing sphere formation
and the identification of ABCG2 in the adult human cochlea
and the first investigation in which brain-dead organ donors
were a source of cochleas used for research.
The accurate identification of stem cells in vivo remains a
major obstacle to understanding in stem cell biology since
there are no single and universal stem cell markers common
to all adult stem cells (17).
To identify evidence of stem or progenitor cells in the adult
human cochlea, we used a sphere-forming assay validated
for neonatal mice (16) that has been used to test the sphere-
forming capacity of cells from adult mice (10). We identified
spheres in two out of three experiments; nevertheless, the
number of spheres was minimal, and no further testing could
be adequately performed for further characterization.
Prior research has demonstrated that neonatal mice have a
cochlear side population that expresses the stem cell marker
ABCG2 (11). Several authors have established that the direct
identification of ABCG2 in this tissue is a marker of this side
population (18-20). We have used flow cytometric analysis to
reveal the presence of ABCG2 in adult human dissociated
cochleas. We have been unable to sort and regrow ABCG2-
positive populations due to the small number of cells obtained
in our experiments, but testing to determine whether these
cells behave similarly to mouse cochlear side population/
ABCG2-positive cells would be extremely valuable (12-14).
A greater number of cochlear cells could be obtained for
the aforementioned experiments via the collection of more
cochleas from brain-dead organ donors, the standardization
of the procedure for membranous cochlear resection, and the
development of greater expertise with this procedure. Vari-
ability and little reproducibility in the removal of membra-
nous cochlear tissue have been reported previously (1).
However, with more widespread use of this material, this
issue can be solved.
We have demonstrated evidence of the presence of progen-
itor cells in the adult human cochlea in the form of sphere
formation and the detection of ABCG2. These findings do
not conclusively establish the presence of stem cells in this
tissue, but they do open a new field for stem cell research.
We have reported the first use of brain-dead organ donors for
cochlear resection for research purposes; this approach can
be of inestimable value for hearing research.
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